Aardvark Therapeutics, Inc. Common Stock (AARD) stock news · $284.4M cap
Aardvark Therapeutics, Inc. Common Stock (AARD) is a biotechnology company listed on US.
This AARD news page leads with what Aardvark Therapeutics, Inc. Common Stock filed — not a scraped headline mill.
No cached 8-K sentence for AARD yet. We will not pad this page with generic market recap.
Latest reported AARD revenue for 2025-12-31 was $0. Net income was -$57.6M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. AARD currently screens at market cap $284.4M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the AARD stock page; for the tape open the quote page.
AARD stock news FAQ
What is AARD's latest net income?
Latest cached Aardvark Therapeutics, Inc. Common Stock (AARD) net income was -$57.6M. Statements: https://lician.com/financials/aard
What is AARD's market cap?
Aardvark Therapeutics, Inc. Common Stock (AARD) market cap is $284.4M on the latest cached fundamentals snapshot.
What kind of company is AARD?
Aardvark Therapeutics, Inc. Common Stock (AARD) is a biotechnology company listed on US.
Where is AARD stock news listed?
Cached stock news for Aardvark Therapeutics, Inc. Common Stock (AARD) is listed at https://lician.com/news/aard. Filings: https://lician.com/sec/aard
Not investment advice.